Verification register Bio, Health & Neuro
Living definition
What is CRMA-1001 (nChroma Bio epigenetic editor)?
Synthetic Biology & Gene Editing Bio, Health & Neuro
- As of
- 2026-09-22
- Revision
- 2026-10-06.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
CRMA-1001 is an epigenetic editing therapy from nChroma Bio designed to switch a target gene’s activity on or off without changing the underlying DNA sequence.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-09-22, verified readiness is 41 (claimed 45, reported 45, gap 4) — Growing evidence strength; current signals suggest Track; not yet.
The readiness fact belongs to the canonical Readiness Verdict for CRMA-1001 (nChroma Bio epigenetic editor).
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06